31,695 Shares in Amicus Therapeutics, Inc. (NASDAQ:FOLD) Purchased by Aigen Investment Management LP

Aigen Investment Management LP bought a new position in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) during the third quarter, Holdings Channel reports. The fund bought 31,695 shares of the biopharmaceutical company’s stock, valued at approximately $385,000. A number of other institutional investors also recently bought and sold shares of the company. Vanguard […]

Leave a Reply

Your email address will not be published.

Previous post National Bank Financial Downgrades Wheaton Precious Metals (TSE:WPM) to Sector Perform Overweight
Next post Taylor Morrison Home Co. (NYSE:TMHC) Shares Acquired by Invesco Ltd.